Exchange Bulletin

Neighbourly Pharmacy Inc. (NBLY) To Trade On Toronto Stock Exchange

May 20, 2021
Issuer: Neighbourly Pharmacy Inc. (the "Company")
Security: Common shares (the "Shares")
Symbol: NBLY
Issue price per security: $17.00
Number of securities issued and outstanding: 33,443,005 Shares
Number of securities reserved for issuance: 3,344,300 Shares
Listing category: Industrial, Non-Exempt Issuer
Trading currency: CDN$
Transaction: Initial public offering of Shares (the "Offering")
Listing date: May 21, 2021 (as at 5:01 p.m.) in anticipation of closing of the Offering
Anticipated closing date: May 25, 2021 (prior to the opening)
Posted for trading date: May 25, 2021 (at the opening) subject to confirmation of closing of the Offering
Other market(s): None
Temporary market maker: Integral Wealth Securities Limited
Security ownership registration: Uncertificated Issue – Non-Certificated Inventory
Investor relations: Terri Smyth
Chief Financial Officer and Secretary
(416) 684-4544
Incorporation: Canada Business Corporations Act
Fiscal year end: On the last Saturday in March
Nature of business: The Company is an operator of community pharmacies in Canada.
Transfer agent and registrar: Computershare Investor Services Inc. at its principal offices in Montréal and Toronto
Dividends: It is the expectation of the Board to declare quarterly cash dividends following Closing. Initially, the Company anticipates paying quarterly cash dividends, with annualized aggregate dividend payments of approximately $6 million (or $0.18 per Share). The first dividend that would be payable after Closing would be the dividend for the period from the Closing of the Offering up to and including June 19, 2021. Such dividend is expected to be paid on September 7, 2021 to shareholders of record as of August 17, 2021. The Company expects that the first dividend would be equal to an aggregate amount of approximately $0.4 million (or approximately $0.01 per Share). The amount and timing of the payment of any dividends are not guaranteed and are subject to the discretion of the Board.
Sponsorship: Waived
Disclosure document: Prospectus dated May 17, 2021, which is available at Capitalized terms not otherwise defined herein are as defined in the disclosure document.
Initial public offering: The Offering consists of 10,295,000 Shares issued from treasury being offered to the public at a price of $17.00 per Share (the "Offering Price") for total gross proceeds of $175,015,000 to the Company. In addition, the Selling Shareholders, entities affiliated with Persistence Capital Partners ("PCP"), have granted the Underwriters an over-allotment option pursuant to which the Underwriters may purchase up to an additional 1,544,250 Shares at the Offering Price.
Concurrently with and conditional upon closing of the Offering, Rx Sidecar II, L.P., an entity affiliated with PCP, has agreed to purchase from the Company, on a prospectus-exempt basis in Canada, 1,058,823 Shares at the Offering Price for aggregate gross proceeds to the Company of $17,999,991.
TSX contact: Chris Birkett,
Managing Director,
Toronto Stock Exchange